Here’s a multibillion-dollar idea: A weight-loss shot. At least that’s what investors in pharmaceutical stocks like Novo Nordisk (NVO), Eli Lilly (LLY), Amgen (AMGN) and Pfizer (PFE) are hoping. They want to see companies parlay their diabetes drugs into obesity treatments with long-term benefits for patients struggling to lose weight. […]
Trending Tags
Friday, Sep 22, 2023